Building on Eight Decades of Innovation

At the core of all we do is our commitment to fostering meaningful and productive partnerships with our customers. This is an approach that has been in our DNA since Flexan Founded in 1946 by the Lilleberg Brothers, Flexan began as a pioneer in rubber molding and engineered elastomer solutions. As the medical device industry evolved, Flexan transformed from a component manufacturer into a global contract development and manufacturing partner serving some of the world's leading healthcare companies.

Through strategic expansion, advanced manufacturing capabilities, international growth, and key acquisitions, Flexan has continuously invested in innovation to help customers bring life-changing medical technologies to market. Today, as part of Ingersoll Rand's Life Sciences platform, Flexan combines decades of engineering expertise with a global manufacturing footprint to support complex medical device programs from concept through commercialization.

Timeline of Flexan history highlighting key milestones from 1946 through 2026, including global expansion, acquisitions, manufacturing growth, and 80 years of medical device innovation.

A Legacy of Growth and Innovation

1946

Flexan is Founded

The Lilleberg Brothers establish Flexan, laying the foundation for a business focused on precision rubber molding and engineered elastomer solutions.

1980

Flexan Medical Industries Established

Flexan expands its focus on healthcare applications through the formation of Flexan Medical Industries (FMI), strengthening its position in the medical device market.

2003

First PICC Delivered

Flexan reaches a significant product milestone with the delivery of its first Peripherally Inserted Central Catheter (PICC), supporting the growing needs of the vascular access market.

2004

Suzhou Facility Opens

Flexan opens its Suzhou manufacturing facility, expanding rubber molding capabilities and increasing support for customers worldwide.

2016

Medron Acquisition

The acquisition of Medron expands Flexan's vascular access portfolio and enhances expertise in advanced medical device manufacturing.

2018

IntroMed Acquisition

Flexan acquires IntroMed, broadening its drug delivery system capabilities and strengthening its position in specialized medical technologies.

2019

Advancing Complex Extrusions

Flexan expands its manufacturing capabilities with advanced complex extrusion technologies supporting vascular access applications.

2020

FDA-Registered Finished Device Manufacturing in China

Flexan achieves a major milestone with the first FDA-registered finished medical device manufactured at its Suzhou facility, further strengthening its global manufacturing footprint.

2021

Acquired by ILC Dover

Flexan joins ILC Dover, creating new opportunities for growth, innovation, and expanded customer solutions.

2023

Expansion into Tijuana, Mexico

Flexan expands operations into Tijuana, Mexico, increasing manufacturing capacity and enhancing supply chain flexibility for customers.

2024

Joining Ingersoll Rand Life Sciences

Flexan becomes part of Ingersoll Rand's Life Sciences platform, strengthening its ability to deliver advanced solutions across the medical device industry.

2025

Sheridan Acquisition

Flexan acquires Sheridan, adding in-house tooling, rapid prototyping, and micromolding capabilities that accelerate product development and commercialization.

2026

80 Years of Excellence

Flexan celebrates 80 years of engineering expertise, manufacturing innovation, and trusted partnerships that continue to shape the future of medical technology.

Looking Ahead

For more than 80 years, Flexan has remained committed to solving complex manufacturing challenges for medical device innovators. What began as a rubber molding company has evolved into a global partner offering advanced medical device manufacturing, engineering support, extrusion, molding, assembly, micromolding, and contract development services.

As healthcare technologies continue to advance, Flexan remains focused on helping customers accelerate innovation, improve patient outcomes, and bring the next generation of medical devices to market.